Agilent Technologies, Inc. (A)

137,74 +1,37 (+1,00 %) À la clôture : 04:00PM EDT

Agilent Technologies, Inc.

5301 Stevens Creek Boulevard
Santa Clara, CA 95051
United States
800 227 9770
https://www.agilent.com

Secteur(s): Healthcare
Secteur d’activité: Diagnostics & Research
Employés à temps plein: 17 700

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Michael R. McMullen	CEO, President & Director	1,91M	16,94M	1961
Mr. Robert W. McMahon	Senior VP, CFO and Interim President of Diagnostics & Genomics Group	1,08M	S.O.	1969
Mr. Padraig McDonnell	Chief Operating Officer	1,06M	S.O.	S.O.
Mr. Henrik Ancher-Jensen	Senior VP and President of Order Fulfillment & Supply Chain	927,44k	S.O.	1965
Mr. Rodney Gonsalves	Principal Accounting Officer, VP & Corporate Controller	S.O.	S.O.	1966
Mr. John Kohl	Senior Vice President & Chief Information Officer	S.O.	S.O.	S.O.
Ms. P. Diana Chiu	VP, Interim General Counsel & Secretary	S.O.	S.O.	S.O.
Mr. Dominique P. Grau	Senior Vice President of Human Resources & Global Communications	936,31k	S.O.	1959
Ms. Allison Ballmer	Senior Vice President of Strategy & Corporate Development	S.O.	S.O.	S.O.
Ms. Yvonne Mackie	MD of UK & Ireland Operations and VP of Human Resources - Europe	S.O.	S.O.	S.O.

Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Agilent Technologies, Inc. en date du 1 avril 2024 est 8. Les scores principaux sont Audit : 8; Société : 4; Droits des actionnaires : 9; Compensation : 4.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.